The Biz Post

Register
Login

September 22-23, 2022 Meeting of the Oncologic Drugs Advisory Committee (ODAC) - Day 1 - U.S. Food and Drug Administration

by

During the first session of September 22, 2022, the committee will discuss new drug application (NDA) 215643, for poziotinib tablets, submitted by Spectrum P...

Published: 2022-09-22 22:45:57


No comments yet.